Shandong Boyuan Pharmaceutical&Chemical
301617
FORSTAR
835640
Cre8 Direct(Ningbo)Co.,Ltd.
300703
Minami Acoustics
301383
ASR Microelectronics
688220
CN Stock MarketDetailed Quotes
000766 Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
- 16.05
- +0.47+3.02%
Not Open Dec 11 15:00 CST
15.51BMarket Cap297.22P/E (TTM)
16.35High15.47Low386.06KlotVolume15.59Open15.58Pre Close619.17MTurnover4.00%Turnover Ratio356.67P/E (Static)966.49MShares22.3052wk High6.62P/B15.50BFloat Cap12.1252wk Low17.14Limit Up966.01MShs Float24.99Historical High14.02Limit Down5.65%Amplitude1.18Historical Low--Dividend TTM16.04Avg Price162.01KlotAsk--Div YieldTTM100Lot Size201.66KlotBid
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -4.98%961.94M | -8.35%635.34M | -12.09%305.4M | -6.30%1.36B | -0.53%1.01B | 5.34%693.23M | 17.37%347.39M | -3.29%1.45B | -8.85%1.02B | -8.72%658.11M |
| Refunds of taxes and levies | ---- | ---- | ---- | -98.20%418.48 | ---- | ---- | ---- | -99.03%23.29K | --2.16K | --1.66K |
| Cash received relating to other operating activities | -19.42%32.55M | -50.67%13.25M | 101.88%11.39M | 75.23%39.45M | -28.64%40.39M | 99.10%26.87M | -44.89%5.64M | -59.74%22.51M | 38.17%56.6M | -57.33%13.49M |
| Cash inflows from operating activities | -5.54%994.48M | -9.93%648.59M | -10.27%316.79M | -5.05%1.4B | -2.01%1.05B | 7.22%720.1M | 15.29%353.03M | -5.47%1.47B | -7.18%1.07B | -10.76%671.6M |
| Goods services cash paid | 60.65%183.22M | 78.40%148.34M | 115.48%99.34M | -12.57%188.03M | -17.32%114.05M | 14.36%83.15M | 31.09%46.1M | 12.63%215.07M | -11.59%137.94M | -31.88%72.71M |
| Staff behalf paid | -3.88%106.74M | -4.71%73.08M | -8.59%38.34M | 0.77%144.23M | 1.16%111.05M | -1.15%76.69M | -1.21%41.94M | -8.79%143.12M | -3.11%109.78M | -2.83%77.58M |
| All taxes paid | -24.63%69.91M | -25.91%46.41M | -32.15%25.79M | 34.54%115.33M | 55.94%92.76M | 64.38%62.64M | 91.67%38.02M | -13.61%85.72M | -20.16%59.48M | -31.74%38.11M |
| Cash paid relating to other operating activities | -19.49%523.21M | -24.94%342.66M | -25.29%164.52M | 0.90%835.89M | -4.22%649.87M | 7.39%456.52M | 9.03%220.22M | -14.61%828.47M | -11.56%678.53M | -15.05%425.11M |
| Cash outflows from operating activities | -8.75%883.08M | -10.09%610.48M | -5.28%327.99M | 0.87%1.28B | -1.83%967.73M | 10.68%679M | 15.64%346.28M | -10.22%1.27B | -11.28%985.73M | -17.41%613.5M |
| Net cash flows from operating activities | 31.01%111.41M | -7.28%38.11M | -265.83%-11.2M | -43.09%112.78M | -4.11%85.04M | -29.25%41.1M | -0.26%6.75M | 43.25%198.16M | 90.71%88.68M | 496.25%58.1M |
| Investing cash flow | ||||||||||
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -86.55%45K | -84.81%45K | ---- | -79.00%334.56K | -76.10%334.56K | --296.2K | --296.2K | 58.18%1.59M | 39.03%1.4M | ---- |
| Cash received relating to other investing activities | -97.24%2.85M | -98.16%1.9M | -100.00%2.14K | 1,498.41%104.14M | 2,670.33%103.2M | 3,590.12%103.2M | 5,317.97%101.33M | 224.98%6.52M | 259.31%3.73M | 36,489.40%2.8M |
| Cash inflows from investing activities | -97.20%2.89M | -98.12%1.94M | -100.00%2.14K | 1,188.53%104.48M | 1,920.12%103.54M | 3,600.71%103.49M | 5,333.81%101.62M | -74.41%8.11M | -83.32%5.13M | -90.58%2.8M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 58.67%26.19M | 54.52%17.83M | -27.92%4.45M | 12.32%26.67M | -1.34%16.51M | 22.64%11.54M | -10.82%6.17M | -6.81%23.74M | -9.00%16.73M | -29.01%9.41M |
| Cash paid relating to other investing activities | -23.75%2.85M | -66.06%949.8K | -99.90%1.77K | -16.58%4.68M | -0.29%3.74M | -0.68%2.8M | -0.26%1.86M | 185.52%5.61M | 97.38%3.75M | 213.01%2.82M |
| Cash outflows from investing activities | 43.46%29.04M | 30.98%18.78M | -44.62%4.45M | 6.80%31.34M | -1.15%20.24M | 17.26%14.34M | -8.58%8.03M | 6.95%29.35M | 0.96%20.48M | -13.61%12.23M |
| Net cash flows from investing activities | -131.39%-26.15M | -118.89%-16.84M | -104.75%-4.45M | 444.33%73.13M | 642.51%83.29M | 1,045.39%89.16M | 1,453.08%93.59M | -599.80%-21.24M | -247.10%-15.35M | -160.69%-9.43M |
| Financing cash flow | ||||||||||
| Cash from borrowing | 80.38%234.5M | 80.38%234.5M | 80.38%234.5M | -91.91%130M | -91.91%130M | 420.00%130M | --130M | 3,917.50%1.61B | 6,328.00%1.61B | 0.00%25M |
| Cash received relating to other financing activities | --7.57M | --7.57M | --7.56M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 86.21%242.07M | 86.21%242.07M | 86.20%242.06M | -91.91%130M | -91.91%130M | 420.00%130M | --130M | 3,917.50%1.61B | 5,764.98%1.61B | -8.76%25M |
| Borrowing repayment | -42.34%131M | -42.78%130M | -42.78%130M | -86.33%227.2M | -86.17%227.2M | 330.45%227.2M | 900.37%227.2M | 467.66%1.66B | 823.85%1.64B | -57.73%52.78M |
| Dividend interest payment | 1.48%63.82M | -0.15%42.18M | -4.58%20.6M | -5.96%83.32M | -4.70%62.89M | -5.05%42.24M | 2.04%21.58M | -9.13%88.6M | -9.83%66M | -11.00%44.49M |
| Cash payments relating to other financing activities | -51.77%31.6M | --2.22M | --2.51M | 14,867.59%73.34M | --65.52M | ---- | --0 | -87.94%490K | ---- | ---- |
| Cash outflows from financing activities | -36.33%226.42M | -35.28%174.39M | -38.46%153.11M | -78.08%383.86M | -79.18%355.61M | 177.01%269.44M | 467.17%248.78M | 344.07%1.75B | 569.87%1.71B | -45.63%97.27M |
| Net cash flows from financing activities | 106.94%15.65M | 148.54%67.68M | 174.88%88.95M | -75.78%-253.86M | -122.66%-225.61M | -92.95%-139.44M | -170.80%-118.78M | 59.25%-144.42M | 55.48%-101.33M | 52.30%-72.27M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 276.16%100.91M | 1,068.95%88.95M | 497.51%73.31M | -309.06%-67.95M | -104.55%-57.28M | 61.10%-9.18M | 58.10%-18.44M | 115.34%32.5M | 83.59%-28M | 81.30%-23.6M |
| Add:Begin period cash and cash equivalents | -28.89%167.25M | -28.89%167.25M | -28.89%167.25M | 16.03%235.21M | 16.03%235.21M | 16.03%235.21M | 15.54%235.21M | -51.10%202.7M | -51.10%202.7M | -51.10%202.7M |
| End period cash equivalent | 50.72%268.16M | 13.35%256.2M | 10.98%240.56M | -28.89%167.25M | 1.85%177.92M | 26.20%226.03M | 35.85%216.76M | 16.03%235.21M | -28.35%174.7M | -37.88%179.1M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongzhun Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongzhun Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
